The Relation Between Hospital Procedure Volume and Complications of Cardioverter-Defibrillator Implantation From the Implantable Cardioverter-Defibrillator Registry

被引:63
作者
Freeman, James V. [1 ]
Wang, Yongfei [2 ]
Curtis, Jeptha P. [2 ]
Heidenreich, Paul A. [3 ]
Hlatky, Mark A. [1 ]
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA
关键词
defibrillation; epidemiology; morbidity; mortality; PERCUTANEOUS CORONARY INTERVENTIONS; UNITED-STATES; PACEMAKER-IMPLANTATION; PRIMARY ANGIOPLASTY; SURGEON VOLUME; OUTCOMES; MORTALITY; OPERATOR; PHYSICIANS;
D O I
10.1016/j.jacc.2010.07.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We sought to examine the relationship between hospital implantable cardioverter-defibrillator (ICD) implantation volume and procedural complications in a contemporary, representative population. Background Hospitals that perform higher volumes of procedures generally have better clinical outcomes. Methods We examined initial ICD implantations between January 2006 and December 2008 at hospitals participating in the NCDR (National Cardiovascular Data Registry) ICD Registry and evaluated the relationship between hospital annual implant volume and in-hospital adverse outcomes. Results The rate of adverse events declined progressively with increasing procedure volume (p trend < 0.0001). This relationship remained significant (p trend < 0.0001) after adjustment for patient clinical characteristics, operator characteristics, and hospital characteristics. The volume-outcome relationship was evident for all ICD subtypes, including single-chamber (p trend = 0.004), dual-chamber (p trend < 0.0001), and biventricular ICDs (p trend = 0.02). Conclusions Patients who have an ICD implanted at a high-volume hospital are less likely to have an adverse event associated with the procedure than patients who have an ICD implanted at a low-volume hospital. (J Am Coll Cardiol 2010;56:1133-9) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:1133 / 1139
页数:7
相关论文
共 50 条
[41]   Procedure, management, and outcome of subcutaneous implantable cardioverter-defibrillator extraction in clinical practice [J].
De Filippo, Paolo ;
Migliore, Federico ;
Palmisano, Pietro ;
Nigro, Gerardo ;
Ziacchi, Matteo ;
Rordorf, Roberto ;
Pieragnoli, Paolo ;
Di Grazia, Angelo ;
Ottaviano, Luca ;
Francia, Pietro ;
Pisano, Ennio ;
Tola, Gianfranco ;
Giammaria, Massimo ;
D'Onofrio, Antonio ;
Botto, Giovanni Luca ;
Zucchelli, Giulio ;
Ferrari, Paola ;
Lovecchio, Mariolina ;
Valsecchi, Sergio ;
Viani, Stefano .
EUROPACE, 2023, 25 (06)
[42]   TOTAL PECTORAL IMPLANTATION - A NEW TECHNIQUE FOR IMPLANTATION OF TRANSVENOUS DEFIBRILLATOR LEAD SYSTEMS AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR [J].
CAMUNAS, J ;
MEHTA, D ;
IP, J ;
PE, E ;
GOMES, JA .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1993, 16 (07) :1380-1385
[43]   Complications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR® Implantable Cardioverter-Defibrillator Registry) [J].
Gleva, Marye J. ;
Wang, Yongfei ;
Curtis, Jeptha P. ;
Berul, Charles I. ;
Huddleston, Charles B. ;
Poole, Jeanne E. .
AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (10) :1891-1898
[44]   Risk of Failure of Transvenous Implantable Cardioverter-Defibrillator Leads [J].
Borleffs, C. Jan Willem ;
van Erven, Lieselot ;
van Bommel, Rutger J. ;
van der Velde, Enno T. ;
van der Wall, Ernst E. ;
Bax, Jeroen J. ;
Rosendaal, Frits R. ;
Schalij, Martin J. .
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (04) :411-416
[45]   Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System [J].
Gold, Michael R. ;
El-Chami, Mikhael F. ;
Burke, Martin C. ;
Upadhyay, Gaurav A. ;
Niebauer, Mark J. ;
Prutkin, Jordan M. ;
Herre, John M. ;
Kutalek, Steven ;
Dinerman, Jay L. ;
Knight, Bradley P. ;
Leigh, Jill ;
Lucas, Lindsay ;
Carter, Nathan ;
Brisben, Amy J. ;
Aasbo, Johan D. ;
Weiss, Raul .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (05) :383-397
[46]   Shouldn't Everyone Have an Implantable Cardioverter-Defibrillator? [J].
Passman, Rod ;
Kadish, Alan .
CIRCULATION, 2009, 120 (22) :2166-2167
[47]   The dilemma of implantable cardioverter-defibrillator therapy in the geriatric population [J].
Revenco, Diana ;
Morgan, James P. ;
Tsao, Lana .
JOURNAL OF GERIATRIC CARDIOLOGY, 2011, 8 (03) :195-200
[48]   Prognostic Importance of Atrial Fibrillation in Implantable Cardioverter-Defibrillator Patients [J].
Borleffs, C. Jan Willem ;
van Rees, Johannes B. ;
van Welsenes, Guido H. ;
van der Velde, Enno T. ;
van Erven, Lieselot ;
Bax, Jeroen J. ;
Schalij, Martin J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (09) :879-885
[49]   Implantable Cardioverter-Defibrillator Shocks Epidemiology, Outcomes, and Therapeutic Approaches [J].
Borne, Ryan T. ;
Varosy, Paul D. ;
Masoudi, Frederick A. .
JAMA INTERNAL MEDICINE, 2013, 173 (10) :859-865
[50]   Implantable cardioverter-defibrillator therapy in the elderly: The continuing quest for data [J].
Barsheshet, Alon ;
Huang, David T. .
CARDIOLOGY JOURNAL, 2011, 18 (05) :473-475